Do you know someone who wants to learn about Health Policy PhD programs? Tell them to register for the Harvard Health Policy Admissions Info Session. Tuesday, 10/28/25 @ 2 pm Eastern.

I had the great privilege of interviewing @johncawley.bsky.social for the ASHEcon newsletter. Check out our discussion and several other great interviews in the fall edition of the newsletter! www.ashecon.org/category/new...

Ben Sommers and I have a new piece up at @jamahealthforum.com on how to think about generalizing lessons from unwinding to looming new Medicaid red tape requirements. jamanetwork.com/journals/jam... We appreciate support from the @commonwealthfund.org for this work!

A new study from researchers at UNC found that only 32.7% of substance use disorder treatment facilities offered perinatal programs. Learn more about their findings here: buff.ly/RDZcx4U

Pragya Kakani giving a great talk on integration of oncologists at #IHEA2025.

When plans for the car ferry fall through, try plan B… Now safely in Bali for #IHEA2025.

The true cost of the reconciliation bill will be measured in lives—over 50,000 per year. It’s a predictable result when you cut off insurance to people who are old, poor and sick. Eric Roberts @pennldi.bsky.social and I discuss @msnbc.com @harvardhpm.bsky.social www.msnbc.com/opinion/msnb...

So excited to see Carolyn San Soucie present on health care utilization around age 19 Medicaid redetermination at @ashecon.bsky.social

HPM's Adrianna McIntyre chats with @wbur.org about potential implications of Medicaid cuts on children, work requirements, and more. @adrianna.bsky.social @hsph.harvard.edu

Eric Roberts and @joefigs.bsky.social led a groundbreaking new study on Medicaid and Medicare, out today in NEJM. I’m lucky to have been a part of it. Medicare saves lives. But is it enough to save lives of the most vulnerable Americans? The study suggests no; Medicaid still matters. (1/11)

Veterans in Medicare Advantage and Traditional Medicare used dental and vision services at similar rates, with no significant difference in total spending. #SGIM25 https://ja.ma/3ZficKj#SGIM25

Excited to share new work in @jama.com on launch prices for cancer drugs in Medicare Part D. Prices are going up, but no trend change post-IRA. Mean monthly launch prices increased from $10,954 in 2012-2014 to $27,891 in 2023-2025. Many thanks to @arnoldventures.bsky.social for funding this work!

Loss of Subsidized Drug Coverage and Mortality among Medicare Beneficiaries | New England Journal of Medicine www.nejm.org/doi/full/10.... How important is help with drug costs? For dual Medicare-Medicaid beneficiaries, it saves lives.

This interview and spending a day asking AI to “teach me” about a policy topic have me equally terrified + impressed. After AI gave clear bulleted answers to my questions and it ranked answers in importance, it offered to give me a playbook to persuade…

**What has slowed health care spending growth in the U.S. over the past two decades?** www.nejm.org/doi/full/10....

The Value Zeitgeist — Considering the Slowdown in Health Care Spending Growth | New England Journal of Medicine www.nejm.org/doi/full/10.... @melindabbuntin.bsky.social , Carrie Colla, and I argue it's too soon to give up on value-based care.

New @nejm.org study with alarming results. The wealthiest Americans do not live as long as the wealthiest in other countries. In fact, mortality among the wealthiest Americans appeared to be similar to people in the poorest quartile in northern and western Europe. www.nejm.org/doi/full/10....